BioSpace News Archive

Business

Tivity Health to Issue Third Quarter 2018 Financial Results After Market Close on November 5

Tivity Health, Inc. (NASDAQ: TVTY) today announced that its financial results for the third quarter ending September 30, 2018, will be released after market close on Monday, November 5, 2018, followed the same day by a conference call and live webcast scheduled for 5:00 p.m. ET.

October 1, 2018
·
1 min read
Business

InventHelp Inventor Develops Shower and Bathtub Cleaning Tool (DLL-3404)

An inventor from Wylie, Texas, has developed the BACK SAVER, a cleaning tool that allows a person to effectively clean a bathtub and surrounding shower area without bending or straining or getting down on hands and knees.

October 1, 2018
·
1 min read
Biotech Beach

Adagio Medical Treats First Atrial Fibrillation Patients Using New One Shot+™ Cryoablation Catheter

Adagio Medical, Inc., the developer of the iCLAS™ technology, the company’s ultra-low temperature intelligent continuous lesion ablation system for the treatment of cardiac arrhythmias, announces that the first patients were successfully treated with its new One Shot+™ cryoablation catheter.

October 1, 2018
·
2 min read
Business

Fluidigm Announces Conference Call and Webcast of Third Quarter 2018 Financial Results

Fluidigm Corporation announced today that it will report third quarter financial results on Thursday, November 1, 2018, after the close of the market.

October 1, 2018
·
2 min read
Business

Zimmer Biomet Holdings Announces Audio Webcast and Conference Call of Third Quarter 2018 Results

Zimmer Biomet Holdings, Inc. today announced its third quarter sales and earnings conference call will be broadcast over the Internet on Friday, October 26, 2018, at 8:30 a.m. Eastern Time.

October 1, 2018
·
1 min read
Drug Development

John Theurer Cancer Center Enrolls First Two Patients Nationwide for Groundbreaking Phase II Clinical Trial for Glioblastoma

Physicians at the John Theurer Cancer Center at Hackensack Meridian Health Hackensack University Medical Center have enrolled the first two patients nationwide in an international phase II clinical trial of Kazia Therapeutics’s novel therapy, GDC-0084, for glioblastoma.

October 1, 2018
·
6 min read
Genetown

Neon Therapeutics to Present at the Society for Immunotherapy of Cancer 33rd Annual Meeting

Neon Therapeutics, Inc. (Nasdaq: NTGN), a clinical-stage immuno-oncology company developing neoantigen-based therapeutics, today announced upcoming presentations at the Society for Immunotherapy of Cancer (SITC) 33rd Annual Meeting, taking place November 9-11, 2018 in Washington, D.C.

October 1, 2018
·
2 min read
Business

Nektar Therapeutics Strengthens Board of Directors with Appointment of Veteran Biotechnology Executive Karin Eastham

Nektar Therapeutics (Nasdaq: NKTR) today announced that it has appointed Karin Eastham as an independent director to its Board of Directors.

October 1, 2018
·
3 min read
Biotech Bay

Pulse Biosciences to Present at the 2018 Cantor Global Healthcare Conference

Pulse Biosciences, Inc. announced today that Darrin Uecker, President and Chief Executive Officer, is scheduled to present at the Cantor Global Healthcare Conference in New York at 4:00 p.m. Eastern Time on Wednesday, October 3rd, 2018.

October 1, 2018
·
1 min read
Pharm Country

CVS Health Celebrates its 30,000 Pharmacists during American Pharmacists Month

CVS Health (NYSE: CVS) is recognizing its 30,000 pharmacists as part of American Pharmacists Month, an annual observation held in October.

October 1, 2018
·
4 min read